| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by operating activities | 52,469 | 4,886 |
| Purchases of property and equipment | 35 | 33 |
| Net cash used in investing activities | -35 | -33 |
| Proceeds from exercise of stock options and employee stock purchase plan | 94 | 94 |
| Net cash provided by (used in) financing activities | 94 | 94 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -680 | -654 |
| Net increase (decrease) in cash and cash equivalents | 51,848 | 4,293 |
| Cash and cash equivalents at beginning of period | 88,559 | - |
| Cash and cash equivalents at end of period | 140,407 | - |
IRONWOOD PHARMACEUTICALS INC (IRWD)
IRONWOOD PHARMACEUTICALS INC (IRWD)